+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
Severe Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Moderate Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2024 - Product Thumbnail Image

Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rosacea - Pipeline Insight, 2024 - Product Thumbnail Image

Rosacea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Contact Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic hand eczema - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic hand eczema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Genital Warts - Pipeline Insight, 2024 - Product Thumbnail Image

Genital Warts - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
Chronic Spontaneous Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Lamellar Icthyosis - Pipeline Insight, 2024 - Product Thumbnail Image

Lamellar Icthyosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Necrobiosis Lipoidica - Pipeline Insight, 2024 - Product Thumbnail Image

Necrobiosis Lipoidica - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Radiodermatitis- - Pipeline Insight, 2024 - Product Thumbnail Image

Radiodermatitis- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Netherton Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Netherton Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Seborrhoeic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Dermal Erythema - Pipeline Insight, 2024 - Product Thumbnail Image

Dermal Erythema - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Onycholysis - Pipeline Insight, 2024 - Product Thumbnail Image

Onycholysis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Dyschromia - Pipeline Insight, 2024 - Product Thumbnail Image

Dyschromia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Keloids - Pipeline Insight, 2024 - Product Thumbnail Image

Keloids - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more